What is this medicine used for?
FDA-approved uses
- Obsessive-compulsive disorder — Adults and children 8 years and older. Age-specific initial and maximum doses.Fluvoxamine maleate immediate-release tablets.
- Obsessive-compulsive disorder — Adults directly studied; pediatric ER use requires individual assessment. Direct pediatric ER studies lacking; do not transfer adult starting dose.Fluvoxamine maleate extended-release capsules.
What should I expect?
Improvement in intrusive thoughts and compulsions usually develops over several weeks or longer. Nausea or changes in sleep can appear before benefit.
Follow-up should consider how much time OCD takes from your day, as well as mood, sleep and side effects. Contact your prescriber if symptoms worsen or treatment is not helping; do not increase the dose yourself.
How do I take it safely?
Take the exact tablet or extended-release capsule prescribed, with or without food. Swallow extended-release capsules whole. Pediatric tablet treatment is established from age 8; the extended-release product has not been directly studied in children and its starting strength may be unsuitable.
Do not combine with an MAOI, linezolid or intravenous methylene blue; antidepressant switches need checked waiting periods. Tizanidine, thioridazine, alosetron, pimozide and ramelteon must not be combined. Ask the pharmacist to check all medicines, especially clozapine, warfarin, theophylline, methadone, sedatives and other medicines affecting serotonin. Aspirin and anti-inflammatory pain medicines can increase bleeding risk. Avoid alcohol.
Follow mood, OCD symptoms, sleep and sexual effects; children need growth monitoring. Older adults and people with liver disease need extra care, and sodium or other tests may be needed. Discuss pregnancy or breastfeeding; late-pregnancy exposure can affect a newborn.
Plan gradual stopping with the prescriber. For a missed dose, take it when remembered unless the next dose is near; then skip it. Do not double.
Tell the clinician about seizures, bleeding disorders or previous low sodium.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Nausea, sleepiness or insomnia, sweating, tremor, weakness and sexual effects.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)FLUVOXAMINE MALEATE- fluvoxamine maleate capsule, extended release
- View FDA Prescribing Information (PDF) (opens in a new tab)Fluvoxamine immediate-release tablets — Preferred Pharmaceuticals
Which warning signs need help?
- Contact the prescriber promptly for new suicidal thoughts, worsening depression or unusual behavior. Use emergency care if there is immediate danger or the person cannot stay safe.
- Seek urgent medical assessment for agitation or confusion with fever, sweating, diarrhea, tremor or rigid muscles: this can be serotonin syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care.. Severe symptoms need emergency care. Seek emergency care for a seizure, collapse, serious breathing difficulty, facial or throat swelling, or suspected overdose.
- Promptly report unusual bleeding, marked confusion or unsteadiness, new reduced need for sleep or extreme excitement. These can reflect bleeding, low sodium or mania. Sudden eye pain or blurred vision needs urgent eye assessment.
What else should I know to stay safe?
- Do not combine with MAOIs, linezolid, intravenous methylene blue, tizanidine, thioridazine, alosetron, pimozide or ramelteon. Medicine switches need checked waiting periods; many other medicines, including clozapine, methadone, warfarin and sedatives, need interaction review. Avoid alcohol.
- Review liver disease, seizures, bleeding risks and low sodium. Monitor mood and adverse effects; children need growth monitoring, and extended-release pediatric evidence differs from tablet evidence. Discuss pregnancy and breastfeeding because newborn or infant effects are possible.
- Arrange gradual stopping with the prescriber to reduce withdrawal risk. Do not use after a known allergy to fluvoxamine or its ingredients.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- A medicine can belong to the antidepressant family without having a US depression approval. Fluvoxamine’s covered US labels are for OCD.
- Tablets and extended-release capsules are not interchangeable starting options for children. The capsule’s lowest strength can be too high for a child who has never taken the medicine.
- An interaction may become important when another medicine is started or stopped, even when your fluvoxamine dose stays the same.
How does it work?
Fluvoxamine slows the return of serotonin, a chemical messenger, into the nerve cells that released it. More serotonin can then remain available between cells. This is thought to contribute to its effect on obsessive-compulsive disorder, or OCD, although the full connection between the transport change and improvement in obsessions and compulsions is not established.
How was this medicine developed?
Luvox tablets received FDA approval in 1994, followed by the extended-release Luvox CR product in 2008. The two formulations contain the same medicine but have different administration instructions and pediatric evidence.
How do I say the name?
Fluvoxamine: floo-VOX-a-meen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Immediate-release tablets
Pediatric tablet dosing from age 8; divide higher daily doses.
Extended-release capsules
Adult bedtime regimen; pediatric ER not directly studied.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Fluvoxamine maleate tablets prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: 1 Indications and Usage; 7.1 Potential Interactions with Drugs that Inhibit or are Metabolized by Cytochrome P450 Isoenzymes; 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics..
- Fluvoxamine: FDA approval history
- Fluvoxamine: patient medicine information
- Fluvoxamine ER: current prescribing information
- Luvox CR: FDA approval history
- View FDA-approved prescribing information (PDF) — immediate-release tablets
- Fluvoxamine: Package Insert / Prescribing Information / MOA
- DailyMed - FLUVOXAMINE MALEATE tablet
- Clomipramine: prescribing information
- Luvox CR: FDA prescribing information
- Fluvoxamine: verified neutral parent, PubChem CID 5324346
- What Is a Neurotransmitter? — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..
- ISMP List of Confused Drug Names
- Serotonin syndrome: MedlinePlus Medical Encyclopedia
- Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Giving medicine safely to children: family guide (PDF, 3 pages)

